Google's AI model proposes a novel drug combination for cancer detection, marking a milestone in AI-driven scientific ...

The American Association of Clinical Endocrinology (AACE) has released its 2025 Consensus Statement, introducing a ...

Despite impressive efficacy across a range of tumour types, their role in activating the immune system results in frequent immune-related adverse events (irAE). While gastrointestinal, endocrine ...

The European Society for Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) have released today ...

Financial stress is costing Canadian employers nearly $70 billion in lost productivity each year. A bold new idea introduced by researchers at Canada’s Financial Wellness Lab based at Western ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...

Key points A 55-year-old man with a left-sided goiter and local compression symptoms presented to our endocrinology clinic. He did not have dysphagia, dyspnea, or hoarseness. All laboratory results, ...

The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood ...